Advertisement
Advertisement
IRMD
iRadimed Corporation
84.55
USDSponsored
-1.00
-1.16%
Nov 06, 11:53 UTC -5
Open
iRadimed Corporation (IRMD) Earnings
IRMD Earnings Reports
Positive Surprise Ratio
IRMD beat 37 of 43 last estimates.
86%
Next Report
Date of Next Report
Feb 08, 2027
Estimate for Q4 26 (Revenue/ EPS)
$26.28M
/$0.62
Implied change from Q3 26 (Revenue/ EPS)
+8.59%
/+12.73%
Implied change from Q4 25 (Revenue/ EPS)
+15.82%
/+14.81%
iRadimed Corporation earnings per share and revenue
On Oct 30, 2026, IRMD reported earnings of 0.55 USD per share (EPS) for Q3 26, missing the estimate of 0.55 USD, resulting in a -1.66% surprise. Revenue reached 24.20 million, compared to an expected 23.94 million, with a 1.12% difference. The market reacted with a -10.57% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.62 USD, with revenue projected to reach 26.28 million USD, implying an increase of 12.73% EPS, and increase of 8.59% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Tandem Diabetes Care, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.24
Actual
-$0.10
Surprise
+59.55%
Artivion, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.06
Actual
$0.08
Surprise
+228.00%
Mobia Medical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.04%
Treace Medical Concepts, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.67%
Inogen Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.56
Surprise
-285.41%
Envoy Medical, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.68
Actual
-$0.50
Surprise
+26.47%
Mettler-Toledo International
Report Date
Nov 05, 2026 For Q3 26
Estimate
$12.21
Actual
$12.57
Surprise
+2.90%
Teleflex Incorporated
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.92
Actual
$2.63
Surprise
+36.82%
Pulse Biosciences, Inc Common Stock (DE)
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.32
Surprise
+14.05%
TransMedics Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.29
Actual
$0.51
Surprise
+71.31%
FAQ
What were iRadimed Corporation's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, iRadimed Corporation reported EPS of $0.55, missing estimates by -1.66%, and revenue of $24.20M, 1.12% above expectations.
How did the market react to iRadimed Corporation's Q3 2026 earnings?
The stock price moved down -10.57%, changed from $85.74 before the earnings release to $76.68 the day after.
When is iRadimed Corporation expected to report next?
The next earning report is scheduled for Feb 08, 2027.
What are the forecasts for iRadimed Corporation's next earnings report?
Based on --
analysts, iRadimed Corporation is expected to report EPS of $0.62 and revenue of $26.28M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.